GlassScriptPhysician profile
Davis A Romney
NPI 1497782916
$8,603.38
in general payments reported to CMS, 2019-2025
61 companies · $3,894 in 2025
The $3,894 reported for 2025 was more than what 94% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $411 · 2021: $1,158 · 2022: $708 · 2023: $908 · 2024: $1,085 · 2025: $3,894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,734 · Travel and Lodging: $1,133 · Gift: $19.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,734.30 |
| Travel and Lodging | $1,132.74 |
| Gift | $19.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Onmark, INC. | $2,590.89 | 2025 | |
| Janssen Biotech, INC. | $532.06 | 2019-2025 | Tecvayli, Darzalex, Talvey |
| Novartis Pharmaceuticals Corporation | $474.79 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $374.25 | 2020-2025 | Enhertu, Lynparza, Imfinzi |
| Eisai INC. | $357.21 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $282.92 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Abbvie INC. | $269.89 | 2023-2025 | Lupron Depot |
| Bayer Healthcare Pharmaceuticals INC. | $254.83 | 2019-2025 | |
| Pfizer INC. | $248.22 | 2021-2025 | |
| Seagen INC. | $192.88 | 2021-2022 | |
| Genzyme Corporation | $189.95 | 2019-2025 | |
| Daiichi Sankyo INC. | $186.20 | 2020-2025 | Enhertu, Injectafer |
| Endomagnetics LTD | $172.87 | 2023 | Magtrace, Magseed |
| Amgen INC. | $171.27 | 2020-2023 | Lumakras |
| Glaxosmithkline, LLC. | $170.70 | 2021-2025 | Jemperli, Zejula, Ojjaara |
Show all 61 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Davis Romney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.